Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
Por:
Hirsch, HH, Martino, R, Ward, KN, Boeckh, M, Einsele, H, Ljungman, P
Publicada:
15 ene 2013
Resumen:
Community-acquired respiratory virus (CARV) infections have been recognized as a significant cause of morbidity and mortality in patients with leukemia and those undergoing hematopoietic stem cell transplantation (HSCT). Progression to lower respiratory tract infection with clinical and radiological signs of pneumonia and respiratory failure appears to depend on the intrinsic virulence of the specific CARV as well as factors specific to the patient, the underlying disease, and its treatment. To better define the current state of knowledge of CARVs in leukemia and HSCT patients, and to improve CARV diagnosis and management, a working group of the Fourth European Conference on Infections in Leukaemia (ECIL-4) 2011 reviewed the literature on CARVs, graded the available quality of evidence, and made recommendations according to the Infectious Diseases Society of America grading system. Owing to differences in screening, clinical presentation, and therapy for influenza and adenovirus, ECIL-4 recommendations are summarized for CARVs other than influenza and adenovirus.
Filiaciones:
Hirsch, HH:
Univ Basel, Dept Biomed, CH-4003 Basel, Switzerland
Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland
Martino, R:
Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Hematol, Barcelona, Spain
Ward, KN:
UCL, Div Infect & Immun, London WC1E 6BT, England
Boeckh, M:
Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA
Einsele, H:
Univ Wurzburg, Dept Internal Med 2, D-97070 Wurzburg, Germany
Ljungman, P:
Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
Karolinska Inst, Dept Med Huddinge, Div Hematol, Stockholm, Sweden
Green Published, Hybrid Gold
|